Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy-Reference-Cited by-同舟云学术

Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy

Published:2021-10-19 Issue:49 Volume:33 Page:2103471
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Xie Feng¹²,Su Peng³,Pan Ting⁴,Zhou Xiaoxue³,Li Heyu³,Huang Huizhe⁵,Wang Aijun⁶,Wang Fangwei³,Huang Jun³,Yan Haiyan¹,Zeng Linghui¹,Zhang Long³^ORCID,Zhou Fangfang²^ORCID

Affiliation:

1. School of Medicine Zhejiang University City College Hangzhou 310015 China

2. Institutes of Biology and Medical Science Soochow University Suzhou 215123 China

3. MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network Life Sciences Institute Zhejiang University Hangzhou 310058 China

4. Center for Infection and Immunity Studies School of Medicine Sun Yat‐sen University Shenzhen 518107 China

5. Faculty of Basic Medical Sciences Chongqing Medical University Medical College Road 1 Chongqing 400016 China

6. Department of Surgery School of Medicine UC Davis Davis CA 95817 USA

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202103471

Reference79 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019